임상 미생물학 시장 규모 조사 : 제품별, 시료 유형별, 최종 사용자별, 용도별, 지역별 예측(2022-2032년)

Global Clinical Microbiology Market is valued approximately at USD 7.80 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 10.91% over the forecast period 2024-2032. Clinical microbiology investigates microorganisms that cause infectious diseases and focuses on isolating and characterizing infectious organisms such as bacteria, viruses, parasites, and fungi to manage and treat patients. The increasing occurrence of infectious diseases, growing awareness of disease prevention, and increasing healthcare expenditure are all factors driving the use of clinical microbiology. Problems concerning quality assurance and management in clinical microbiology laboratories coupled with limited availability of equipment and infrastructure can pose a challenge to product penetration in the market. Additionally, technological advancements in clinical microbiology instruments and processes present various opportunities for medical laboratory businesses to expand their portfolio and increase profitability.

The Global Clinical Microbiology Market is experiencing robust growth, propelled by several key factors. The escalating prevalence of infectious diseases worldwide has necessitated advanced diagnostic methods, which clinical microbiology provides. Enhanced awareness regarding disease prevention, supported by increased healthcare expenditure, further fuels the demand for sophisticated microbiology testing solutions. For instance, significant investments exceeding USD 500 million have been allocated by leading healthcare institutions and governments towards the development and adoption of advanced microbiology testing technologies. This investment reflects the commitment to improving diagnostic accuracy and patient outcomes. However, the complexity of quality assurance in clinical microbiology laboratories, combined with limited availability of advanced equipment and infrastructure in certain regions, poses challenges to market growth.

The key regions considered for the global Clinical Microbiology market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America holds a significant share in the market, driven by a strong presence of leading market players and substantial investments in research & development. The region's well-developed pharmaceutical and healthcare sectors further contribute to the adoption of advanced clinical diagnostic techniques. Meanwhile, the Asia Pacific region is expected to witness the highest growth rate during the forecast period, attributed to the increasing popularity of molecular diagnosis and the booming medical tourism industry. In Europe, the rising prevalence of pathogenic diseases and the need for rapid microbiological testing methods enhance the utilization of clinical microbiology technology.

Major market player included in this report are:

• 3M Company
• Abbott Laboratories
• Advanced Instruments, LLC
• Agilent Technologies, Inc.
• B. Braun SE
• Beckman Coulter, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• bioMerieux S.A.
• Cardinal Health, Inc.
• Clinichem Ltd.
• COPAN Diagnostics Inc.
• Diagnostica Longwood S.L.
• ELITech Group
• F. Hoffmann-La Roche Ltd.

The detailed segments and sub-segment of the market are explained below:

By Product

• Instruments
• Reagents

By Specimen Type

• Blood
• Body fluids
• Cerebrospinal Spinal Fluid
• Fecal
• Saliva
• Serum
• Synovial Fluid
• Urine

By End-User

• Academic & Research Institutes
• Hospitals & Care Providers
• Laboratories

By Application

• Autoimmune Diseases
• Cardiology
• Diabetes
• Drug Testing
• Gastrointestinal Diseases
• Nephrology
• Oncology
• Periodontal Diseases
• Respiratory Diseases
• Sexually Transmitted Diseases

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Clinical Microbiology Market Executive Summary

• 1.1. Global Clinical Microbiology Market Size & Forecast (2022- 2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Product
  • 1.3.2. By Specimen Type
  • 1.3.3. By End-User
  • 1.3.4. By Application
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Clinical Microbiology Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Clinical Microbiology Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Increasing Prevalence of Infectious Diseases
  • 3.1.2. Growing Awareness of Disease Prevention
  • 3.1.3. Increasing Healthcare Expenditure
• 3.2. Market Challenges
  • 3.2.1. Quality Assurance and Management Issues
  • 3.2.2. Limited Availability of Equipment and Infrastructure
• 3.3. Market Opportunities
  • 3.3.1. Technological Advancements in Microbiology Instruments
  • 3.3.2. Expanding Medical Laboratory Businesses
  • 3.3.3. Growth in Molecular Diagnosis

Chapter 4. Global Clinical Microbiology Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top investment opportunity
• 4.4. Top winning strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Clinical Microbiology Market Size & Forecasts by Product 2022-2032

• 5.1. Segment Dashboard
• 5.2. Global Clinical Microbiology Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 5.2.1. Instruments
  • 5.2.2. Reagents

Chapter 6. Global Clinical Microbiology Market Size & Forecasts by Specimen Type 2022-2032

• 6.1. Segment Dashboard
• 6.2. Global Clinical Microbiology Market: Specimen Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 6.2.1. Blood
  • 6.2.2. Body Fluids
  • 6.2.3. Cerebrospinal Spinal Fluid
  • 6.2.4. Fecal
  • 6.2.5. Saliva
  • 6.2.6. Serum
  • 6.2.7. Synovial Fluid
  • 6.2.8. Urine

Chapter 7. Global Clinical Microbiology Market Size & Forecasts by End-User 2022-2032

• 7.1. Segment Dashboard
• 7.2. Global Clinical Microbiology Market: End-User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 7.2.1. Academic & Research Institutes
  • 7.2.2. Hospitals & Care Providers
  • 7.2.3. Laboratories

Chapter 8. Global Clinical Microbiology Market Size & Forecasts by Application 2022-2032

• 8.1. Segment Dashboard
• 8.2. Global Clinical Microbiology Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 8.2.1. Autoimmune Diseases
  • 8.2.2. Cardiology
  • 8.2.3. Diabetes
  • 8.2.4. Drug Testing
  • 8.2.5. Gastrointestinal Diseases
  • 8.2.6. Nephrology
  • 8.2.7. Oncology
  • 8.2.8. Periodontal Diseases
  • 8.2.9. Respiratory Diseases
  • 8.2.10. Sexually Transmitted Diseases

Chapter 9. Global Clinical Microbiology Market Size & Forecasts by Region 2022-2032

• 9.1. North America Clinical Microbiology Market
  • 9.1.1. U.S. Clinical Microbiology Market
    • 9.1.1.1. Product breakdown size & forecasts, 2022-2032
    • 9.1.1.2. Specimen Type breakdown size & forecasts, 2022-2032
    • 9.1.1.3. End-User breakdown size & forecasts, 2022-2032
    • 9.1.1.4. Application breakdown size & forecasts, 2022-2032
  • 9.1.2. Canada Clinical Microbiology Market
• 9.2. Europe Clinical Microbiology Market
  • 9.2.1. U.K. Clinical Microbiology Market
  • 9.2.2. Germany Clinical Microbiology Market
  • 9.2.3. France Clinical Microbiology Market
  • 9.2.4. Spain Clinical Microbiology Market
  • 9.2.5. Italy Clinical Microbiology Market
  • 9.2.6. Rest of Europe Clinical Microbiology Market
• 9.3. Asia-Pacific Clinical Microbiology Market
  • 9.3.1. China Clinical Microbiology Market
  • 9.3.2. India Clinical Microbiology Market
  • 9.3.3. Japan Clinical Microbiology Market
  • 9.3.4. Australia Clinical Microbiology Market
  • 9.3.5. South Korea Clinical Microbiology Market
  • 9.3.6. Rest of Asia Pacific Clinical Microbiology Market
• 9.4. Latin America Clinical Microbiology Market
  • 9.4.1. Brazil Clinical Microbiology Market
  • 9.4.2. Mexico Clinical Microbiology Market
  • 9.4.3. Rest of Latin America Clinical Microbiology Market
• 9.5. Middle East & Africa Clinical Microbiology Market
  • 9.5.1. Saudi Arabia Clinical Microbiology Market
  • 9.5.2. South Africa Clinical Microbiology Market
  • 9.5.3. Rest of Middle East & Africa Clinical Microbiology Market

Chapter 10. Competitive Intelligence

• 10.1. Key Company SWOT Analysis
• 10.2. Top Market Strategies
• 10.3. Company Profiles
  • 10.3.1. Agilent Technologies, Inc.
    • 10.3.1.1. Key Information
    • 10.3.1.2. Overview
    • 10.3.1.3. Financial (Subject to Data Availability)
    • 10.3.1.4. Product Summary
    • 10.3.1.5. Market Strategies
  • 10.3.2. B. Braun SE
  • 10.3.3. Beckman Coulter, Inc.
  • 10.3.4. Becton, Dickinson and Company
  • 10.3.5. Bio-Rad Laboratories, Inc.
  • 10.3.6. bioMerieux S.A.
  • 10.3.7. Cardinal Health, Inc.
  • 10.3.8. Clinichem Ltd.
  • 10.3.9. COPAN Diagnostics Inc.
  • 10.3.10. Diagnostica Longwood S.L.
  • 10.3.11. ELITech Group
  • 10.3.12. F. Hoffmann-La Roche Ltd.
  • 10.3.13. 3M Company
  • 10.3.14. Abbott Laboratories
  • 10.3.15. Advanced Instruments, LLC

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes